Theravance Biopharma, Inc. (TBPH) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

Earnings Reports

• Theravance Biopharma (TBPH) Q3 2025: Upelri Net Sales Jump 15% as Cypress Readout Nears
  November 11, 2025
• Theravance Biopharma (TBPH) Q2 2025: UPLRI Sales Jump 22% as Cypress Nears Key Catalyst
  August 12, 2025
• Theravance Biopharma (TBPH) Q1 2025: UPelri Hospital Volume Jumps 48%, Cypress Data Inflection Nears
  July 05, 2025

Browse all companies